Spectral AI Stock Is Soaring Today: What's Going On?

Spectral AI Inc MDAI shares are trading higher Thursday. The company announced that its DeepView SnapShot Wound Imaging System was marked for use in the U.K. and received Class 1 medical device classification with the FDA.

What Happened: Spectral AI, an artificial intelligence company focused on medical diagnostics, said its DeepView SnapShot is now UK Conformity Assessed (UKCA)-marked for use and received Class 1 medical device classification with the FDA in the U.S.

"Spectral AI's commitment to advancing medical diagnostics in tissue health is reflected in these important milestones," said Wensheng Fan, CEO of Spectral AI.

"We are confident that our unique AI-driven imaging platform will empower healthcare professionals in making critical decisions around the world, and these regulatory developments are significant steps towards achieving that goal."

Spectral AI said it now plans to seek regulatory approval for its DeepView AI - Burn software to commercialize the complete DeepView SnapShot System worldwide.

See Also: New York City Mayor Eric Adams Speaks Every Language On Phone Calls — No, Wait ... It's Just AI Cloning

MDAI Price Action: Spectral AI shares were up 53.7% at $3.97 at the time of publication, according to Benzinga Pro.

Photo: 3844328 from Pixabay.